JW Lifescience Corporation (KRX:234080)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,170
-80 (-0.71%)
Last updated: Jun 4, 2026, 2:09 PM KST

JW Lifescience Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8,8648,3797,51120,2223,9204,923
Short-Term Investments
3,3382,1102,1108,12624,953155.05
Cash & Short-Term Investments
12,20210,4899,62228,34828,8735,078
Cash Growth
-53.90%9.01%-66.06%-1.82%468.59%95.88%
Accounts Receivable
42,42643,43643,04855,50553,42632,141
Other Receivables
-1,34416,784252.42346.01257.79
Receivables
42,42644,78059,83255,75753,77237,198
Inventory
30,15331,62235,44823,39922,06721,077
Prepaid Expenses
-131.29159.7824.78236.471,044
Other Current Assets
3,2081,266602.96305.5660.732.79
Total Current Assets
87,98888,289105,664107,834105,00864,430
Property, Plant & Equipment
125,660128,653132,051124,577131,555137,145
Long-Term Investments
585.31582.85558.5710,4194,3908,934
Goodwill
32,38932,38974,266950.99950.99950.99
Other Intangible Assets
44,07944,4903,2202,8703,1003,671
Long-Term Deferred Tax Assets
---15.81--
Long-Term Deferred Charges
178.39192.47248.81305.14484.8689.12
Other Long-Term Assets
22,67323,6109,3158,8657,4533,646
Total Assets
313,552318,206325,324255,836252,942219,467
Accounts Payable
16,67016,90019,61718,74015,11812,496
Accrued Expenses
-1,5401,6691,2711,156724.7
Short-Term Debt
7,50017,80027,70015,70036,68144,350
Current Portion of Long-Term Debt
32,84131,1378,11230,353336336
Current Portion of Leases
363.85296.15350.8244.91131.02159.77
Current Income Taxes Payable
3,2802,0468,5942,7393,6453,279
Other Current Liabilities
20,31414,70714,13625,41122,97622,557
Total Current Liabilities
80,96884,42880,17994,25980,04483,902
Long-Term Debt
--31,89916830,0071,610
Long-Term Leases
1,5461,3391,17646.6840.4231.91
Pension & Post-Retirement Benefits
4,1634,0504,001---
Long-Term Deferred Tax Liabilities
8,0387,7287,4061,8282,0112,243
Other Long-Term Liabilities
88.7382.81217.94141.95508.07187.8
Total Liabilities
94,80497,628124,87996,443112,61087,975
Common Stock
39,58639,58639,58639,58639,58639,586
Additional Paid-In Capital
28,33528,33528,33528,33528,33528,335
Retained Earnings
151,088152,918132,42298,22079,16070,319
Treasury Stock
-6,749-6,749-6,749-6,749-6,749-6,749
Comprehensive Income & Other
6,4876,4876,850000
Shareholders' Equity
218,748220,578200,445159,393140,332131,492
Total Liabilities & Equity
313,552318,206325,324255,836252,942219,467
Total Debt
42,25150,57369,23846,31367,19546,488
Net Cash (Debt)
-30,049-40,084-59,616-17,965-38,322-41,410
Net Cash Per Share
-1941.30-2588.63-3850.39-1160.20-2474.87-2657.82
Filing Date Shares Outstanding
15.4815.4815.4815.4815.4815.48
Total Common Shares Outstanding
15.4815.4815.4815.4815.4815.48
Working Capital
7,0203,86125,48513,57424,965-19,472
Book Value Per Share
14132.0614245.0412944.8210293.699062.748491.82
Tangible Book Value
142,280143,699122,959155,573136,281126,870
Tangible Book Value Per Share
9191.919280.157940.7310046.958801.128193.30
Land
41,31341,31341,31332,45932,45932,459
Buildings
33,26434,08836,98339,82041,64842,618
Machinery
47,68650,04049,26951,45056,83644,976
Construction In Progress
1,5091,5992,987758.47440.7316,903